ORIFARM SUPPLY A/S: Financial statements 2013
CVR: 17153684
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ORIFARM SUPPLY A/S (CVR 17153684) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 3,363,704,000 and a net result of DKK -24,389,000. The profit margin was -0.7%. Equity in the 2013 report amounted to DKK 58,765,000. The solvency ratio was 5.8%.
- Revenue
- DKK 3,363,704,000
- Gross Profit
- DKK 87,332,000
- Profit/Loss
- DKK -24,389,000
- Equity
- DKK 58,765,000
- Total Assets
- DKK 1,009,227,000
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ORIFARM SUPPLY A/S has published its annual report for 2012.
About ORIFARM SUPPLY A/S
ORIFARM SUPPLY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MEDIPACK A/S and SBH2 ApS. The management consists of Mads Fink Eriksen. The board consists of Ole Michael Friis (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by MEDIPACK HOLDING A/S. The company has 188 employees (2026). In 2025, the company reported revenue of DKK 11,714,817,000 and a net result of DKK 253,440,000 compared with DKK 269,398,000 the year before. Equity in the 2025 report amounted to DKK 1,337,548,000.
